Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challenges.
about
Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatmentEffect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice.Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection.Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B.Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation.Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection.Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells.Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.
P2860
Q33747793-D89ABD6F-3503-4AB9-ACA4-A32A05DA9762Q33784869-F8898EC7-1DDA-4DE8-A7AD-6EEB8AEA92F5Q34252890-30E37CF2-3EFC-4755-8304-BBC442975BC3Q35054759-ECAB5DDB-32D1-4C72-84B8-B336F73A00CFQ35772972-15C82D7E-3AF8-463D-A0E8-6B8C1EBAD652Q37611853-0306ABAD-3C31-427C-9DCE-19DCBB1AD7B3Q37946440-7206DF93-7CCA-4AD1-8835-54102D433516Q42279852-07865007-8C52-49FF-9DE3-435639D63262Q43258398-19DE581A-8FC4-4854-BEAA-AA4C880504BE
P2860
Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challenges.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical immune characterizati ...... tion: Progress and challenges.
@en
type
label
Clinical immune characterizati ...... tion: Progress and challenges.
@en
prefLabel
Clinical immune characterizati ...... tion: Progress and challenges.
@en
P2860
P1433
P1476
Clinical immune characterizati ...... tion: Progress and challenges.
@en
P2093
Fu-Sheng Wang
P2860
P304
P356
10.1111/J.1872-034X.2007.00222.X
P478
37 Suppl 3
P577
2007-10-01T00:00:00Z